BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 21, 2004
View Archived Issues
BMS highlights Q1 developments
Read More
Amylin achieves first three of corporate goals for 2004 during first quarter
Read More
SR-142801 alters endocrine stress response in patients with panic disorder
Read More
Preclinical evidence of the inhibitory effects of AZD-0865 on acid output
Read More
Phase II clinical data on the efficacy of tolevamer in CDAD
Read More
Therapeutic benefits of sargramostim in moderate to severe Crohn's disease
Read More
Ruboxistaurin mesilate may improve symptoms of diabetic peripheral neuropathy
Read More
Positive results reported from phase III trial of alvimopan in opioid-induced bowel dysfunction
Read More
Study confirms previous findings that bicifadine offers fast-acting and safe treatment of pain
Read More
European Commission officially adopts EMEA positive opinion on nimesulide
Read More
IDEA-070 shows excellent efficacy in treatment of UVB-induced skin inflammation
Read More
BioMS Medical seeks clearance to begin pivotal trial of MBP-8298 in Canada
Read More
FDA approves DepoDur for treatment of pain
Read More
Johnson & Johnson acquires Egea Biosciences
Read More
NovaRx completes enrollment ahead of schedule in phase II trial of cancer treatment
Read More
BTG in-licenses novel antitumor agents
Read More
Cerus announces phase IIIc results for Intercept Blood System
Read More
Phase II trial of clofarabine in adult acute leukemia exceeds expectations
Read More
Neurochem updates clinical pipeline progress
Read More
Isotechnika receives clearance to initiate phase I trial of TAFA-93 in Canada
Read More
Phase II/III trial of AIC for treatment of ragweed allergy now fully enrolled
Read More
Progesterone cream ineffective as postmenopausal bone loss prophylaxis
Read More
Ospemifene reduces markers of bone turnover in postmenopausal women
Read More
Preliminary evidence for the efficacy of basiliximab in ulcerative colitis
Read More
Tigecycline potent, broadly active in vitro
Read More
3-Dimensional Pharmaceuticals claims new tyrosine kinase inhibitors and their use
Read More
New p38 MAP kinase inhibitors in early development at Celltech
Read More
Bayer patents a guanylate cyclase activator and its use in cardiovascular disorders
Read More
Three related series of gamma-secretase inhibitors and their use in AD therapy
Read More
Novel factor Xa inhibitors covered by BMS patent
Read More
Pfizer researchers present another series of HIV RT inhibitors
Read More
Novel CCR5 antagonists for transplant rejection, autoimmune diseases, etc.
Read More